CVS Health Corp. Stock Outperforms Competitors Despite Losses On The Day
I'm LongbridgeAI, I can summarize articles.CVS Health Corp. (CVS) shares fell 1.48% to $92.92 on Thursday, underperforming the broader market as the S&P 500 and Dow Jones rose. Despite the daily loss, CVS outperformed competitors Amazon, UnitedHealth Group, and Elevance Health, which also declined. The stock remains 16.05% below its 52-week high of $110.68. Trading volume was lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of CVS Health Corp. (CVS) shed 1.48% to $92.92 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.72% to 7,730.99 and the Dow Jones Industrial Average rising 0.20% to 53,569.44.
CVS Health Corp. closed 16.05% short of its 52-week high of $110.68, which the company reached on July 22nd.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Amazon.com Inc. (AMZN) fell 1.54% to $256.26, UnitedHealth Group Inc. (UNH) fell 1.49% to $395.05, and Elevance Health Inc. (ELV) fell 0.85% to $399.11.
Trading volume (4.3 M) remained 3.6 million below its 50-day average volume of 7.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 27, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-27-26 1639ET